France Becomes Latest EU Member To Allow 'Probiotic' Label For Dietary Supplements
Over The Counter 6 Jan 2023: Prebiotics And Consumer Health: Opportunity, Regulation and Future, With Clasado’s Per Rehné
In this episode, HBW Insight interviews Per Rehné, CEO of UK-based microbiome specialists Clasado Biosciences, about the exciting world of prebiotics. Essentially food for your gut microbiome, prebiotics have benefitted from a worldwide boom in preventative health in recent years, as well as a critical mass of clinical research showing the significant role that the gut plays in health, immunity and even stress and anxiety. In this fascinating discussion, Rehné explains the science behind prebiotic supplementation, as well as the regulatory environment in the European Union that makes marketing such supplements challenging, to say the least. We also dive into the current and future growth and innovation opportunities that prebiotics represent for the consumer health industry, which Clasado supplies, as well as marketing its own Bimuno branded product in the UK and beyond.
More from Europe
In a major milestone for the EU’s pricing and reimbursement landscape, the European Commission has published the first ever, much anticipated, joint clinical assessment report.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Weak demand for virus-blocking nasal sprays since the pandemic has left Austrian biotech Marinomed with mounting debts. The company has applied for restructuring proceedings with an Austrian court in an attempt to secure its future.
Perrigo aims its new SolpaOne high-strength paracetamol effervescent at UK pharmacists, who now have expanded powers as part of the UK government's Pharmacy First initiative.
More from Geography
Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.






